Skip to main content
Content Starts Here GSA Federal Advisory Committee Act (FACA) Database Skip to main content

Committee Detail

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.

HHS - 2635 - National Clinical Care Commission - Statutory (Congress Created)


Committee NameNational Clinical Care CommissionAgency NameDepartment of Health and Human Services
Fiscal Year2020Committee Number2635
Original Establishment Date4/3/2018Committee StatusChartered
Actual Termination Date Committee URL
New Committee This FYNoPresidential Appointments*No
Terminated This FYNoMax Number of Members*23
Current Charter Date4/3/2020Designated Fed Officer Position Title*Designated Federal Officer
Date Of Renewal Charter4/3/2022Designated Federal Officer Prefix
Projected Termination Date9/30/2021Designated Federal Officer First Name*Jennifer
Exempt From Renewal*NoDesignated Federal Officer Middle NameAnne
Specific Termination AuthorityDesignated Federal Officer Last Name*Bishop
Establishment Authority*Statutory (Congress Created)Designated Federal Officer SuffixScD
Specific Establishment Authority*Public Law 115-80Designated Federal Officer Phone*(240) 453-8826
Effective Date Of Authority*11/2/2017Designated Federal Officer Fax*
Exempt From EO 13875 Discretionary CmteNot ApplicableDesignated Federal Officer Email*
Committee Type*Continuing
Committee Function*National Policy Issue Advisory Board


Agency Recommendation*Continue
Legislation to Terminate RequiredNot Applicable
Legislation StatusNot Applicable
How does cmte accomplish its purpose?*The National Clinical Care Commission evaluates and makes recommendations regarding improvements to the coordination and leveraging of programs within the Department and other Federal agencies related to awareness and clinical care for diabetes and its complications. The NCCC accomplishes its purpose by meeting at least twice, but not more than four times a year to discuss issues, develop recommendations, and prepare reports. Between these public meetings, the committee members work within three subcommittees: prevention of the general population, prevention of the targeted population, and treatment and complications. The work of the subcommittees is presented to the full Commission during the public meetings. By October 2021, the Commission shall submit to the Secretary and Congress a final report containing all of the findings and recommendations required.
How is membership balanced?*The Commission consists of 23 voting members. The composition includes eleven ex-officio members and twelve non-federal public members. The ex-officio members consist of the heads of, or subordinate officials designated by the heads of, the following federal departments, agencies, or components: The Centers for Medicare and Medicaid Services, the Agency for Healthcare Research and Quality, the Centers for Disease Control and Prevention, the Indian Health Service, the Department of Veterans Affairs, the National Institutes of Health, the Food and Drug Administration, the Health Resources and Services Administration, the Department of Defense, the Department of Agriculture, and the Office of Minority Health. Of the non-federal members at least one individual is from each of the following categories: physician specialties, including clinical endocrinologists, that play a role in the prevention or treatment of diseases and complications; primary care physicians; non-physician health care professionals; patient advocates; national experts, including public health experts; and health care providers furnishing services to a patient population that consists of a high percentage (as specified by the Secretary) of individuals who are enrolled in a State plan under title XIX of the Social Security Act or who are not covered under a health plan or health insurance coverage. The members were appointed by the Secretary of Health and Human Services and consideration was given to ensure that there is a broad representation of geographic areas, gender, race, ethnicity, and disability.
How frequent & relevant are cmte mtgs?*It is stipulated in the charter that the Commission will meet at least twice and not more than four times a year. The Commission discusses topics and issues that are critical for developing the report that must be submitted to the Secretary and Congress to comply with the authorizing statute.

On November 22, 2019, the NCCC held its fifth meeting to discuss literature and field examples regarding the social determinants of health. The Commission also heard presentations from HUD, DOT, USDA, and CDC.

On February 19, 2020, the NCCC held its sixth meeting, focused on CMS programs and policies. CMS representatives presented on numerous topics. The Diabetes Care and Prevention Model was unanimously approved.

On June 26, 2020, the seventh meeting of the Commission, each subcommittee presented a summary from stakeholder calls, input from the data call and federal agencies, and discussed synthesis and future directions.

On September 11, 2020, the eighth meeting, each subcommittee presented draft recommendations and next steps.
Why advice can't be obtained elsewhere?*As of yet, this the only collective body with representation from relevant federal agencies and non-federal diabetes experts that can provide a comprehensive knowledge base to evaluate federal programs that relate to the prevention of diabetes, approaching high-risk populations, and addressing treatment and complications. The National Clinical Care Commission is the first collective effort that includes federal and non-federal members to evaluate federal programs related to diabetes within HHS and selected non-HHS agencies. The Commission is in the process of making recommendations regarding improvements to the coordination and leveraging of programs within the Department and other Federal agencies related to awareness and clinical care for diabetes.
Why close or partially close meetings?Not applicable. There were no closed meetings in FY-20.

All meetings of the Commission will be open to the public unless it is determined by the Secretary or designee that a meeting will be closed and/or partially closed because the topics to be discussed are confidential and/or sensitive in nature.
Recommendation Remarks


Outcome Improvement To Health Or Safety*YesAction Reorganize Priorities*No
Outcome Trust In GovernmentNoAction Reallocate ResourcesNo
Outcome Major Policy ChangesYesAction Issued New RegulationsNo
Outcome Advance In Scientific ResearchYesAction Proposed LegislationNo
Outcome Effective Grant MakingNoAction Approved Grants Or Other PaymentsNo
Outcome Improved Service DeliveryYesAction OtherNo
Outcome Increased Customer SatisfactionNoAction CommentNot Applicable
Outcome Implement Laws/Reg RequirementsNoGrants Review*No
Outcome OtherNoNumber Of Grants Reviewed 
Outcome CommentNot ApplicableNumber Of Grants Recommended 
Cost Savings*Unable to DetermineDollar Value Of Grants Recommended 
Cost Savings CommentThe duty of NCCC is to gather information about federal programs related to the charge, analyze and evaluate those programs, and provide recommendations to the Secretary and Congress for the coordination and leveraging of programs within HHS and other federal agencies related to awareness and clinical care for diabetes. Cost savings is not among the description of duties of the Commission, and therefore cannot be determined.Grants Review CommentNot Applicable
Number Of Recommendations*0Access Contact Designated Fed. Officer*Yes
Number Of Recommendations CommentAll findings and recommendations are to be reported in the final report to the Secretary and Congress within three years of the Commission’s first meeting on October 31, 2018. According to the operating plan, the first year consists of information gathering, a high level inventory, and data call. The second year consists of an analysis of the federal programs obtained from the data call. It is expected that the subcommittees’ work will broaden and deepen the evaluation during year 2020. The third year, 2021, is dedicated to refinement of the analysis and development of recommendations for the final report. The charter stipulates that all findings and recommendations be contained in the final report, and therefore there are no recommendations to report for FY-20.Access Agency WebsiteYes
% of Recs Fully Implemented*0.00%Access Committee WebsiteYes
% of Recs Fully Implemented CommentNot ApplicableAccess GSA FACA WebsiteYes
% of Recs Partially Implemented*0.00%Access PublicationsNo
% of Recs Partially Implemented CommentNot ApplicableAccess OtherNo
Agency Feedback*Not ApplicableAccess CommentAccess to information and reports regarding NCCC can be obtained from the DFO or from the ODPHP website ( There have been no publications; thus, they cannot be accessed.
Agency Feedback Comment*The Commission is currently in the information gathering and analysis stage of the operating plan. A draft of recommendations is expected to be compiled in 2021 and shall be reviewed by the agency for feedback to be finalized.Narrative Description*The National Clinical Care Commission Act (NCCA) was passed into law by Congress in November 2017 to establish within the Department of Health and Human Services (HHS) a National Clinical Care Commission Advisory Committee (NCCC or Commission). The Commission will be responsible for evaluating HHS programs that focus on prevention, current activities and gaps in federal efforts to support clinicians in providing integrated care, improvement in federal education and awareness activities related to prevention and treatment, methods for outreach and dissemination of education and awareness materials, and opportunities for consolidation of overlapping federal programs.
Hide Section - COSTS


Payments to Non-Federal Members*$0.00Est Payments to Non-Fed Members Next FY*$0.00
Payments to Federal Members*$47,120.00Est. Payments to Fed Members Next FY*$48,345.00
Payments to Federal Staff*$258,028.00Estimated Payments to Federal Staff*$270,209.00
Payments to Consultants*$0.00Est. Payments to Consultants Next FY*$0.00
Travel Reimb. For Non-Federal Members*$6,009.00Est Travel Reimb Non-Fed Members nextFY*$6,081.00
Travel Reimb. For Federal Members*$810.00Est Travel Reimb For Fed Members*$820.00
Travel Reimb. For Federal Staff*$0.00Est. Travel Reimb to Fed Staff Next FY*$0.00
Travel Reimb. For Consultants*$0.00Est Travel Reimb to Consultants Next FY*$0.00
Other Costs$408,000.00Est. Other Costs Next FY*$413,140.00
Total Costs$719,967.00Est. Total Next FY*$738,595.00
Federal Staff Support (FTE)*1.00Est. Fed Staff Support Next FY*1.00
Cost RemarksReimbursement for travel and per diem for federal members is not from the NCCC budget, but paid by the member's federal agency.Est Cost Remarks
Hide Section - Interest Areas

Interest Areas

Food and Drugs
Food and Drugs
Medical Devices
Federal Government
Internal Federal Government
State Government
Tribal Government
Health Care
Medical Education
Medical Practitioners
Nutrition for Women, Infants and Children
Public Health
Research and Statistics
Health and Health Research
Basic Research
Research and Development
Research and Statistics
Science and Technology
Science and Technology
Social Sciences
Social Sciences
Benchmark and Clinical Trials Research Studies
Veterans and Veterans' Medical Care


To View all the members, meetings and advisory reports for this committee please click here




ActionCommittee System IDSubcommittee NameFiscal Year
 COM-035074Prevention-General Population2020
 COM-035075Prevention-Targeted Population2020
 COM-035076Treatment and Complications2020


No Documents Found



Data from Previous Years

ActionCommittee System IDCommittee NameFiscal Year
 COM-036430National Clinical Care Commission2019
 COM-034636National Clinical Care Commission2018